An investigation on behalf of current long term investors in Trevena, Inc. (NASDAQ: TRVN) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
San Diego, CA -- (SBWIRE) -- 09/30/2019 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Trevena, Inc..
Investors who are current long term investors in Trevena, Inc. (NASDAQ: TRVN) shares, have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: TRVN stocks follows a lawsuit filed against Trevena, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: TRVN stocks, concerns whether certain Trevena directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that Trevena misled its shareholders to believe that its April 28, 2016 End-of-Phase 2 Meeting with the United States Food and Drug Administration ("FDA") was far more successful than it actually was.
Those who purchased shares of Trevena, Inc. (NASDAQ: TRVN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels